Literature DB >> 19608594

Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey.

Jan Stritzke1, Patrick Linsel-Nitschke, Marcello Ricardo Paulista Markus, Björn Mayer, Wolfgang Lieb, Andreas Luchner, Angela Döring, Wolfgang Koenig, Ulrich Keil, Hans-Werner Hense, Heribert Schunkert.   

Abstract

AIMS: Degenerative aortic valve disease (DAVD), a common finding in the elderly, is associated with an increased risk of death due to cardiovascular causes. Taking advantage of its longitudinal design, this study evaluates the prevalence of DAVD and its temporal associations with long-term exposure to cardiovascular risk factors in the general population. METHODS AND
RESULTS: We studied 953 subjects (aged 25-74 years) from a random sample of German residents. Risk factors had been determined at a baseline investigation in 1994/95. At a follow-up investigation, 10 years later, standardized echocardiography determined aortic valve morphology and aortic valve area (AVA) as well as left ventricular geometry and function. At the follow-up study, the overall prevalence of DAVD was 28%. In logistic regression models adjusting for traditional cardiovascular risk factors at baseline age (OR 2.0 [1.7-2.3] per 10 years, P < 0.001), active smoking (OR 1.7 [1.1-2.4], P = 0.009) and elevated total cholesterol levels (OR 1.2 [1.1-1.3] per increase of 20 mg/dL, P < 0.001) were significantly related to DAVD at follow-up. Furthermore, age, baseline status of smoking, and total cholesterol level were significant predictors of a smaller AVA at follow-up study. In contrast, hypertension and obesity had no detectable relationship with long-term changes of aortic valve structure.
CONCLUSIONS: In the general population we observed a high prevalence of DAVD that is associated with long-term exposure to elevated cholesterol levels and active smoking. These findings strengthen the notion that smoking cessation and cholesterol lowering are promising treatment targets for prevention of DAVD.

Entities:  

Mesh:

Year:  2009        PMID: 19608594     DOI: 10.1093/eurheartj/ehp287

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  The Pathogenesis and treatment of the valvulopathy of aortic stenosis: Beyond the SEAS.

Authors:  Sammy Elmariah; Emile R Mohler
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

2.  Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study.

Authors:  Gry Wisthus Eveborn; Henrik Schirmer; Per Lunde; Geir Heggelund; John-Bjarne Hansen; Knut Rasmussen
Journal:  Eur J Epidemiol       Date:  2014-07-15       Impact factor: 8.082

3.  Impact of acquisition and interpretation on total inter-observer variability in echocardiography: results from the quality assurance program of the STAAB cohort study.

Authors:  Caroline Morbach; Götz Gelbrich; Margret Breunig; Theresa Tiffe; Martin Wagner; Peter U Heuschmann; Stefan Störk
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-14       Impact factor: 2.357

4.  Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium.

Authors:  George Thanassoulis; Joseph M Massaro; Ricardo Cury; Emily Manders; Emelia J Benjamin; Ramachandran S Vasan; L Adrienne Cupple; Udo Hoffmann; Christopher J O'Donnell; Sekar Kathiresan
Journal:  J Am Coll Cardiol       Date:  2010-06-01       Impact factor: 24.094

Review 5.  Risk Stratification in Patients With Aortic Stenosis Using Novel Imaging Approaches.

Authors:  Calvin W L Chin; Tania A Pawade; David E Newby; Marc R Dweck
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

Review 6.  Role of oxidative stress in calcific aortic valve disease and its therapeutic implications.

Authors:  Harry Z E Greenberg; Guoan Zhao; Ajay M Shah; Min Zhang
Journal:  Cardiovasc Res       Date:  2022-05-06       Impact factor: 13.081

7.  Risk factor profile of calcific aortic stenosis.

Authors:  I Sathyamurthy; Shaji Alex; K Kirubakaran; G Sengottuvelu; K N Srinivasan
Journal:  Indian Heart J       Date:  2016-04-28

8.  Risk factors for degenerative aortic valve disease in India: A case control study.

Authors:  D S Chadha; S K Malani; P Bharadwaj; G Karthikeyan; P K Hasija
Journal:  Med J Armed Forces India       Date:  2017-04-18

Review 9.  Degenerative Aortic Stenosis, Dyslipidemia and Possibilities of Medical Treatment.

Authors:  Rita Kleinauskienė; Regina Jonkaitienė
Journal:  Medicina (Kaunas)       Date:  2018-04-25       Impact factor: 2.430

Review 10.  Patient Management in Aortic Stenosis: Towards Precision Medicine Through Protein Analysis, Imaging and Diagnostic Tests.

Authors:  Laura Mourino-Alvarez; Tatiana Martin-Rojas; Cecilia Corros-Vicente; Nerea Corbacho-Alonso; Luis R Padial; Jorge Solis; María G Barderas
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.